DR. GEORGE THEODORE SHYBUT, M.D.

CINCINNATI, OH

Research Active
Orthopaedic Surgery NPI registered 21+ years 3 publications 1980 – 1991 NPI: 1023013471
BiopsyDiagnosis, DifferentialLupus Erythematosus, SystemicDogsBone TransplantationCocaineOsteomyelitisDose-Response Relationship, DrugOsteogenesisOsteonecrosisTibiaMandibleOrthopedic Fixation DevicesBone RegenerationDextroamphetamine

Practice Location

4440 GLEN ESTE WITHAMSVILLE RD
CINCINNATI, OH 45245-1318

Phone: (513) 753-7488

What does GEORGE SHYBUT research?

Dr. Shybut studies the impacts of systemic lupus erythematosus, an autoimmune condition, on bone health, specifically looking at rare complications such as osteonecrosis (bone death) in patients. He also explores advanced surgical techniques like distraction osteogenesis, which promotes bone growth in areas such as the jaw. This research is significant for patients with lupus and those needing jawbone repairs due to injuries or defects.

Key findings

  • Dr. Shybut identified a rare case of osteonecrosis in a lupus patient, highlighting potential complications that doctors should monitor.
  • In a study on jawbone regeneration, he demonstrated that a 2.5-centimeter gap in the jaw could be successfully filled within 25 days, growing new bone at a rate of 1 millimeter per day.
  • He found that specific d-N-alkylated amphetamines showed high self-administration rates in animals, suggesting that certain chemical structures are more appealing, which is critical for medication development.

Frequently asked questions

Does Dr. Shybut study lupus?
Yes, he studies complications related to systemic lupus erythematosus, including bone health issues.
What treatments has Dr. Shybut researched?
He has researched surgical techniques like distraction osteogenesis for jawbone regeneration and the efficacy of certain amphetamines.
Is Dr. Shybut's work relevant to patients with jaw injuries?
Yes, his research on jawbone regeneration techniques can significantly benefit patients with jaw injuries or defects.
What are the implications of Dr. Shybut's research on drug development?
His findings on the appeal of certain drug structures can guide pharmaceutical companies in developing better medications.

Publications in plain English

An atypical site of osteonecrosis in a patient with systemic lupus erythematosus.

1991

The Journal of rheumatology

Stolow J, Parikh S, Shybut G, Robinson P, Pope RM

Plain English
This study looked at a patient with systemic lupus erythematosus who developed bone death, known as osteonecrosis, in an unusual spot—the lower part of the leg near the ankle. The doctors had to perform tests to rule out a bone infection after the patient experienced joint issues. This finding is important because it highlights a rare complication of lupus that doctors should be aware of. Who this helps: This helps patients with lupus and their doctors by improving understanding of potential complications.

PubMed

Segmental mandibular regeneration by distraction osteogenesis. An experimental study.

1990

Archives of otolaryngology--head & neck surgery

Costantino PD, Shybut G, Friedman CD, Pelzer HJ, Masini M +2 more

Plain English
This study looked at a method called distraction osteogenesis to help regenerate parts of the jawbone in dogs. Researchers found that they could successfully fill a 2.5-centimeter gap in the jawbone within 25 days, growing new bone at a rate of 1 millimeter per day, while ensuring the new bone was similar in size and function to the original. This is important because it shows a potential new way to repair jawbone defects, which can help improve the quality of life for patients with similar injuries or conditions. Who this helps: This helps patients with jawbone injuries or defects.

PubMed

Structure-activity relationships among some d-N-alkylated amphetamines.

1980

Pharmacology, biochemistry, and behavior

Woolverton WL, Shybut G, Johanson CE

Plain English
This study looked at different versions of a type of drug called d-N-alkylated amphetamines to see how well they work in animals, including monkeys, rats, and guinea pigs. They found that three specific drugs (d-amphetamine, d-N-methylamphetamine, and d-N-ethylamphetamine) led to high self-administration rates, indicating they are more appealing to the animals, while a larger compound (d-N-butylamphetamine) was less effective, with only one out of three test animals choosing it. These findings help to understand how the length of a chemical structure affects drug activity, which is important for developing new medications. Who this helps: This benefits researchers and pharmaceutical companies developing treatments for various conditions.

PubMed

Frequent Co-Authors

J Stolow S Parikh P Robinson R M Pope P D Costantino C D Friedman H J Pelzer M Masini M L Shindo G A Sisson

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.